PBS Calendars

Page last updated: 29 August 2016

PBS related activities surrounding the PBAC meeting cycles

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Pharmaceutical Evaluation Branch to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2016 - 2018

MEETING

2016/2
6-8 July 2016

2016/3
2-4 November

2017/1
8-10 March

2017/2
5-7 July

2017/3
1-3 November

Activity

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Deadline for major submissions (Wednesday)

0

9 March 2016

0

6 July 2016

0

2 Nov 2016

0

8 March 2017

0

5 July 2017

 

1

 

1

 

1

 

1

 

1

 

 

2

 

2

 

2

 

2

 

2

 

 

3

 

3

 

3

 

3

 

3

 

 

4

 

4

 

4

 

4

 

4

 

Submissions to discussants (Wednesday)

Pre submission meetings with companies
(future submissions only)

5

13 Mar 2016

11 Apr – 6 May 2016
(25 Apr PH)

5

10 Aug 2016

8 Aug – 2 Sept 2016

5

7 Dec 2016

5 Dec 2016 – 6 Jan 2017
(26-27 Dec, 2 Jan PH)

5

12 April 2017

10 Apr – 5 May 2017
(14,17,25 Apr PH)

5

9 Aug 2017

7 Aug – 1 Sept 2017

Deadline for minor submissions (including Secretariat listings) (Friday)

6

22 Apr 2016

6

19 Aug 2016

6

16 Dec 2016

6

21 April 2017

6

18 Aug 2017

Publication of PBAC agenda on PBS website (Wednesday)

7

28 Apr 2016

7

24 Aug 2016

7

21 Dec 2016

7

26 April 2017
(25 Apr PH)

7

23 Aug 2017

 

8

 

8

 

8

 

8

 

8

 

 

9

 

9

 

9

 

9

 

9

 

Major submission commentaries to “Responsible Persons”

10

18 May 2016

10

14 Sept 2016

10

18 Jan 2017

10

17 May 2017

10

13 Sept 2017

“Responsible Persons” send Pre-Subcommittee Responses to PBAC Secretariat (by midday Wednesday)

Pre submission meetings with companies
(future submissions only)

11

25 May 2016

 

23-27 May 2016

11

21 Sept 2016

 

19-23 Sept 2016

11

25 Jan 2017

 

23-27 Jan 2017
(26 Jan PH)

11

24 May 2017

 

22-26 May 2017

11

20 Sept 2017

 

18-22 Sept 2017

DUSC meeting (Thursday-Friday)

12

2-3 June 2016

12

29-30 Sept 2016

12

2-3 Feb 2017

12

1-2 June 2017

12

28-29 Sept 2017

ESC meeting (Monday-Tuesday)

 

Closing date for online consumer comments

13

6-7 June 2016

 

8 June 2016

13

4-5 Oct 2016
(3 Oct PH)

5 Oct 2016

13

6-7 Feb 2017


8 Feb 2016

13

5-6  June 2017


7 June 2017

13

3-4 Oct 2017
(2  Oct PH)

4 Oct 2017

ATAGI meeting (Thursday – Friday)

14

16-17 June 2016

14

13-14 Oct 2016

14

16-17 Feb 2017

14

15-16 June 2017

14

12-13 Oct 2017

Minor submission overviews, ESC (major submissions only), DUSC (selected major submissions only), & ATAGI (vaccine
submissions only) advice & summary of consumer comments to “Responsible Persons” (Wednesday)

15

22 June 2016

15

19 Oct 2016

15

22 Feb 2017

15

21 June 2017

15

18 Oct 2017

“Responsible Persons” send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

Pre submission meetings with companies not relating to imminent submissions(future submissions only)

16

29 June 2016

 

27 Jun – 1 July 2016

16

26 Oct 2016

 

24-28 Oct 2016

16

1 March 2017

 

27 Feb – 3 Mar 2017

16

28 June 2017

 

26-30 June 2017

16

25 Oct 2017

 

23-27 Oct 2017

PBAC meeting Wednesday-Friday

(Close for next cycle major submissions on Wednesday)

17

6-8 July 2016

6 July 2016

17

2-4 Nov 2016

2 Nov 2016

17

8-10 Mar 2017

8 Mar 2017

17

5-7 July 2017

5 July 2017

17

1-3 Nov 2017

1 Nov 2017

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive recommendations) to “Responsible Persons” (Friday)

20

29 July 2016

20

25 Nov 2016

20

31 Mar 2017

20

28 July 2017

20

24 Nov 2017

 

21

 

21

 

21

 

21

 

21

 

Ratified Minutes (all other recommendations) to “Responsible Persons” (Friday)

22

12 Aug 2016

22

9 Dec 2016

22

13 Apr 2017
(14 Apr PH)

22

11 Aug 2017

22

8 Dec 2017

Posting of recommendations on website following sponsor’s comments*

23

19 Aug 2016

23

16 Dec 2016

23

21 Apr 2017

23

18 Aug 2017

23

15 Dec 2017

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting

24

26 Aug 2016

24

23 Dec 2016

24

28 Apr 2017

24

25 Aug 2017

24

22 Dec 2017

 

25

 

25

 

25

 

25

 

25

 

 

26

 

26

 

26

 

26

 

26

 

Draft PSDs  to “Responsible Persons”

27

16 Sept 2016

27

20 Jan 2017

27

19 May 2017

27

15 Sept 2017

27

19 Jan 2018

 

28

 

28

 

28

 

28

 

28

 

 

29

 

29

 

29

 

29

 

29

 

 

30

 

30

 

30

 

30

 

30

 

 

31

 

31

 

31

 

31

 

31

 

Finalisation of PSDs (Friday)

32

21 Oct 2016

32

24 Feb 2017

32

23 Jun 2017

32

20 Oct 2017

32

23 Feb 2018

PSDs published on web site (positives & subsequent rejections)

33

28 Oct 2016

33

3 March 2017

33

30 Jun 2017

33

27 Oct 2017

33

2 Mar 2018

 

0

 

0

 

0

 

0

 

0

 

PSDs published on web site (1st time rejections & deferrals)

1

11 Nov 2016

1

17 March 2017

1

14 Jul 2017

1

10 Nov 2017

1

16 Mar 2018

PBAC = Pharmaceutical Benefits Advisory Committee
“responsible persons” = legal wording requirement for terminology – previously known as sponsors
DUSC = Drug Utilisation Sub Committee    
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
    
*  These dates may vary based on the number of submissions received    

Accessibility

The documents on this page may not be accessible. If you need help please contact HTA compliance (secretariat.compliance@health.gov.au).

Suitable Dates for Sponsors to meet with the Pharmaceutical Evaluation Branch (PEB)

It is quite routine for sponsors to meet with relevant officers in the PEB prior to submitting to the PBAC, however, the available opportunities for these meetings is limited by busy periods within the PBAC meeting cycle when key personnel have other priorities.

The weeks in the cycles assigned for PEB-Sponsor meetings can be found in the PBAC Cycle Timeframe Calendar.

Please complete and return the meeting request form (Word 23 KB) to HTA compliance (secretariat.compliance@health.gov.au).

Once your request form has been received and reviewed by the PEB a Departmental officer will be in touch to arrange a meeting time.

If the item to be discussed is a co-dependent technology sponsors must first contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to arrange a joint meeting.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

Further information about the HTA processes can be found on the Department of Health website.